Big drug maker Gilead expects to take a billion-dollar hit this year via drug-pricing provisions in the Inflation Reduction ...

Descovy and Truvada are prescription drugs used to treat and help prevent HIV. Both drugs come as oral tablets that are taken once per day. Truvada is available as a generic drug, while Descovy is ...

The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...

Gilead Sciences Inc. sees 2025 earnings rising faster than Wall Street expected after a big fourth-quarter beat highlighted ...

"This injection…will be critical to addressing ... versions of the drug in some markets), as well as Gilead's follow-up Descovy (emtricitabine and tenofovir alafenamide), a once-daily oral ...

HIV prevention shot achieved a 96% success rate in clinical trials, but accessibility and regulatory hurdles remain a ...

In this month’s issue, the Sexpert advises readers on how to navigate discussions of PrEP and sexual health while in the ...

Terms of the deal were not disclosed in the case, which involved the government’s patents on Gilead’s HIV drugs Truvada and Descovy for pre-exposure prophylaxis (PrEP). The government was ...

PrEP (pre-exposure prophylaxis) is an effective way to reduce the risk of contracting HIV through sexual activity or injection drug use. Currently, there are two oral forms that are taken daily, ...

Prompt injection is the highest profile vulnerability in AI-powered features and applications. It's also one of the most misunderstood. The impact varies greatly depending on who will use the feature, ...